TY - JOUR
T1 - Smoking and periodontal disease
T2 - Discrimination of antibody responses to pathogenic and commensal oral bacteria
AU - Hayman, L.
AU - Steffen, M. J.
AU - Stevens, J.
AU - Badger, E.
AU - Tempro, P.
AU - Fuller, B.
AU - Mcguire, A.
AU - Al-Sabbagh, Mohanad
AU - Thomas, M. V.
AU - Ebersole, J. L.
PY - 2011/4
Y1 - 2011/4
N2 - Smoking is an independent risk factor for the initiation, extent and severity of periodontal disease. This study examined the ability of the host immune system to discriminate commensal oral bacteria from pathogens at mucosal surfaces, i.e. oral cavity. Serum immunoglobulin (Ig)G antibody reactive with three pathogenic and five commensal oral bacteria in 301 current smokers (age range 21-66 years) were examined by enzyme-linked immunosorbent assay. Clinical features of periodontal health were used as measures of periodontitis. Antibody to the pathogens and salivary cotinine levels were related positively to disease severity; however, the antibody levels were best described by the clinical disease unrelated to the amount of smoking. The data showed a greater immune response to pathogens than commensals that was related specifically to disease extent, and most noted in black males. Significant correlations in individual patient responses to the pathogens and commensals were lost with an increasing extent of periodontitis and serum antibody to the pathogens. Antibody to Porphyromonas gingivalis was particularly distinct with respect to the discriminatory nature of the immune responses in recognizing the pathogens. Antibody responses to selected pathogenic and commensal oral microorganisms differed among racial groups and genders. The antibody response to the pathogens was related to disease severity. The level of antibody to the pathogens, and in particular P. gingivalis, was correlated with disease severity in black and male subsets of patients. The amount of smoking did not appear to impact directly serum antibody levels to these oral bacteria.
AB - Smoking is an independent risk factor for the initiation, extent and severity of periodontal disease. This study examined the ability of the host immune system to discriminate commensal oral bacteria from pathogens at mucosal surfaces, i.e. oral cavity. Serum immunoglobulin (Ig)G antibody reactive with three pathogenic and five commensal oral bacteria in 301 current smokers (age range 21-66 years) were examined by enzyme-linked immunosorbent assay. Clinical features of periodontal health were used as measures of periodontitis. Antibody to the pathogens and salivary cotinine levels were related positively to disease severity; however, the antibody levels were best described by the clinical disease unrelated to the amount of smoking. The data showed a greater immune response to pathogens than commensals that was related specifically to disease extent, and most noted in black males. Significant correlations in individual patient responses to the pathogens and commensals were lost with an increasing extent of periodontitis and serum antibody to the pathogens. Antibody to Porphyromonas gingivalis was particularly distinct with respect to the discriminatory nature of the immune responses in recognizing the pathogens. Antibody responses to selected pathogenic and commensal oral microorganisms differed among racial groups and genders. The antibody response to the pathogens was related to disease severity. The level of antibody to the pathogens, and in particular P. gingivalis, was correlated with disease severity in black and male subsets of patients. The amount of smoking did not appear to impact directly serum antibody levels to these oral bacteria.
KW - Antibody
KW - Commensal bacteria
KW - Pathogens
KW - Periodontal disease
KW - Smoking
UR - http://www.scopus.com/inward/record.url?scp=79952499693&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79952499693&partnerID=8YFLogxK
U2 - 10.1111/j.1365-2249.2010.04314.x
DO - 10.1111/j.1365-2249.2010.04314.x
M3 - Article
C2 - 21303363
AN - SCOPUS:79952499693
SN - 0009-9104
VL - 164
SP - 118
EP - 126
JO - Clinical and Experimental Immunology
JF - Clinical and Experimental Immunology
IS - 1
ER -